Fluoroquinolones and lower respiratory tract infections

A. Kuhnke, H. Lode

Source: Eur Respir Mon; 2004: 28: 94–112
Journal Issue: Antibiotics and the Lung
Disease area: Respiratory infections

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Kuhnke, H. Lode. Fluoroquinolones and lower respiratory tract infections. Eur Respir Mon; 2004: 28: 94–112

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Lower respiratory tract infections: when are antibiotics mandatory?
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=146
Year: 2004

Antibiotics and new guidelines for the treatment of lower respiratory tract infections
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=175
Year: 2004

Macrolides and lower respiratory tract infections
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=78
Year: 2004

Treatment of community-acquired lower respiratory tract infections in adults
Source: Eur Respir J 2002; 20: 40S-53S
Year: 2002



Respiratory infections in the immunocompetent host: from asthma exacerbations to hospital-acquired pneumonia
Source: Annual Congress 2007 - Infections year in review
Year: 2007


Impact of appropriate diagnostics on the management of respiratory tract infections
Source: Value-Dx event 2021: Community-acquired respiratory tract infections: where do we stand in 2021, ECCMID 2021
Year: 2021

Prevention of nosocomial infections in acute respiratory failure patients
Source: Eur Respir J 2003; 22: 72S-76S
Year: 2003



Management of lower respiratory tract infections by French general practitioners: the AIR II study
Source: Eur Respir J 2002; 19: 314-319
Year: 2002



Guidelines for management of adult community-acquired lower respiratory tract infections
Source: Guideline 1998
Year: 1998

Influence of antibiotic resistance of pseudomonas aeruginosa on presenting features of community-acquired lower respiratory tract infections
Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis
Year: 2011


Corticosteroids in severe pneumonia
Source: Eur Respir J 2008; 32: 259-264
Year: 2008



The management of severe sepsis in respiratory tract infections
Source: Annual Congress 2013 –ME14 The management of severe sepsis in respiratory tract infections
Year: 2013



Antibiotic prescribing for discoloured sputum in acute cough/lower respiratory tract infection
Source: Eur Respir J 2011; 37: 119-125
Year: 2011



Association of asthma exacerbations and upper respiratory tract infections (URTIs)
Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases
Year: 2009

Does antibiotic treatment of upper respiratory tract infections prevent bacterial LRTIs?
Source: Annual Congress 2009 - PG1 EU GRACE Network Full-day Course: vaccination and preventive measures for LRTIs in the community: what’s new?
Year: 2009



Nosocomial tracheobronchitis in mechanically ventilated patients: incidence, aetiology and outcome
Source: Eur Respir J 2002; 20: 1483-1489
Year: 2002



Antibiotic prescribing for adults with acute cough/lower respiratory tract infection: congruence with guidelines
Source: Eur Respir J 2011; 37: 112-118
Year: 2011



Characteristics of pnemococcal community-acquired pneumonia presenting with respiratory failure
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016


Cardiovascular consequences of community-acquired pneumonia and other pulmonary infections
Source: Eur Respir Monogr 2020; 88: 212-228
Year: 2020


Etiology pathogens structure in community-acquired pneumonias and COPD exacerbations
Source: Annual Congress 2011 - Role of infection in exacerbations of COPD
Year: 2011